Immunology Commercial Lead

Dupixent (dupilumab) represents one of Sanofi's most innovative and transformative immunology assets, delivering life-changing outcomes for patients suffering from Type 2 inflammatory diseases. As a groundbreaking biologic therapy, Dupixent has demonstrated remarkable efficacy across multiple indications, including moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, and other Type 2 inflammatory conditions. This flagship product embodies Sanofi's commitment to addressing significant unmet medical needs and improving the lives of patients with chronic inflammatory diseases.

We are seeking an exceptional Commercial Lead for Dupixent to drive the strategic growth and commercial excellence of this transformative therapy in the Romanian market. This pivotal leadership role offers the opportunity to shape the future of immunology care in Romania while leading a high-performing team dedicated to bringing innovative treatment options to patients and healthcare professionals.